Phase 4 Study - Mucinex D as Adjunct Therapy

Completed · Phase 4

Conditions studied: Acute Respiratory Infection, Bronchitis, Rhinosinusitis

In brief

The objective of the study is to evaluate the safety and efficacy of Mucinex D tablets in providing symptom relief when administered as an adjunct to antibiotic therapy in patients with acute respiratory infection.

Key facts

Study ID
NCT00441246
Run by
Adams Respiratory Therapeutics
People needed
600
Starts
2007-02-01
Expected to finish
2007-07-01
Last updated by the study team
2008-02-06

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.